Site 49: Michigan State University — East Lansing, Michigan

Site 49: Michigan State University is a clinical research site located in East Lansing, Michigan, United States 48824.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 49: Michigan State University has participated in 1 clinical trials.

Therapeutic areas: Myasthenia Gravis, Generalized.

Sponsors: Ra Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 49: Michigan State University?

Site 49: Michigan State University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 49: Michigan State University conducted?

Site 49: Michigan State University has 1 clinical trials on record. Their work covers Myasthenia Gravis, Generalized.

Is Site 49: Michigan State University accredited by Crixeo Health?

Site 49: Michigan State University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 49: Michigan State University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.